| 1.
Your Experience: Select the
appropriate response to indicate whether you know of any errors
in the past year that have occurred in your organization related
to the use of vaccine abbreviations. |
| Areas Where Abbreviations May Appear |
Error(s)? |
| |
Yes |
No |
| a. Handwritten vaccine orders |
42% |
58% |
| b. Preprinted vaccine orders |
15% |
85% |
| c. Vaccine protocols/schedules |
26% |
74% |
| d. Pharmacy vaccine labels |
17% |
83% |
| e. Immunization records (for provider) |
30% |
70% |
| f. Immunization records (for patient) |
29% |
71% |
| g. Pharmacy/prescriber order entry screens |
20% |
80% |
| h. Automated dispensing cabinet screens |
7% |
93% |
| i. Manufacturer product labels |
17% |
83% |
| 2. Your Opinion:
Select the appropriate response to tell us your opinion about
the following statements related to the adoption and use of uniform,
standard abbreviations for vaccines. (See www.cdc.gov/nip/visi/prototypes/vaxabbrev.htm
for a proposed list.) |
|
Statement
|
Agree |
Undecided |
Disagree |
| a. Standard abbreviations should be used for vaccines. |
63% |
8% |
28% |
b. Standard abbreviations for vaccines will reduce the risk
of errors
related to misinterpretation. |
55% |
8% |
36% |
| c. Proposed standard abbreviations for vaccines should fall
into two categories: one for use in clinical settings (without
complex specifiers) and the other for use in scientific publications. |
40% |
20% |
41% |
| d. Computer screens should display the full brand (when applicable)
and generic names of all vaccine products.. |
85% |
9% |
6% |
| e. Preprinted orders and protocols should display the full brand
(when applicable) and generic names of all vaccine products. |
85% |
7% |
7% |
| f. Published immunization schedules should display the full
generic name(s) of all vaccines. |
91% |
7% |
2% |
| g. Standard abbreviations should be used for vaccine peel-off
stickers that are placed on patient records. |
55% |
14% |
32% |
h. Standard abbreviations should be used to designate each component
vaccine for combination products. |
55% |
12% |
34% |
| i. Immunization forms should be designed with space available
to fully list the brand name and each vaccine component. |
81% |
5% |
14% |